Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?

Adham S. Bear, Richard A. Morgan, Kenneth Cornetta, Carl H. June, Gwendolyn Binder-Scholl, Mark E. Dudley, Steven A. Feldman, Steven A. Rosenberg, Sheila A. Shurtleff, Cliona M. Rooney, Helen E. Heslop, Gianpietro Dotti

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?'. Together they form a unique fingerprint.